TCL Archive Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center. July 21, 2000
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s August 6, 1993
TCL Archive In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees January 3, 1992
